Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 97 results for "zydus group cadila healthcare"

Drug launch to keep Cadila Health in focus

Zydus Cadila has launched tablet Tenglyn, the generic version of oral anti-diabetic drug Gliptins, in India. Tenglyn, priced at ₹7 a tablet, is almost a sixth of the price at which Gliptins was initially launched in India. The company had earlier ... Hindu Business Line, 1 week ago
Zydus launches Tenglyn tablets in Indian market Economic Times, 1 week ago

Zydus gets USFDA nod for clinical trials of Sarolitazar

NEW DELHI: Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat levels in body due to diabetes, obesity, and sedentary habits. "United States Food and Drug ...
 Economic Times1 week ago Zydus gets FDA nod for clinical trials of Sarolitazar  Financial Chronicle1 week ago
DNA India

Cadila Healthcare net profit surges 40% to Rs 391 crore in Q2

Its total income has increased from Rs 2,122.61 crore for the quarter ended September 30 in the 2014-15 fiscal to Rs 2,483.19 crore in the second quarter of the current fiscal. Representational Image Pharma firm Cadila Healthcare Ltd ...
 DNA India1 month ago

Zydus announces clinical trials of Saroglitazar in patients with Severe Hypertriglyceridemia in USA

Details Category: Small Molecules Published on Wednesday, 18 November 2015 09:24 Hits: 44 AHMEDABAD, India I November 18, 2015 I Zydus today announced that USFDA has endorsed company's plan to initiate a Phase 2 clinical trial of Saroglitazar ...
 PipelineReview1 week ago

Global Biopharmaceuticals Industry

LONDON, Nov. 26, 2015 /PRNewswire/ This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides separate ...
 Pharmacy Choice1 day ago

Cholesterol-lowering Drugs Market Forecast 2015-2025

Opportunities in PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and PPAR Agonists What can be expected from the cholesterol-lowering drugs market? Which areas are going to grow at the fastest rates? This visiongain report ...
 Fat Pitch Financials4 days ago

Biosimilar market is projected to be worth USD 32 billion worldwide by 2025 According to 'Global Biosimilars Market, 2015-2025'

Dublin, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( ) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering. Overall, with the ...
 Franklin Credit Management Corporation2 weeks ago Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located  Tutorial Finder2 weeks ago Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025  Ulitzer3 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less